Abbott Laboratories (ABT)

102.45 -0.90%
11:37 am EDT; Powered by Koyfin
Stock price low relative to the 52-week range
Revenue growth higher than the industry and sector averages
Forward dividend yield higher than the industry and sector averages
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Company’s profitability is declining
High short interest


  1. ABT stock price ($96.76) is at the 52-week low. Perhaps now is a good time to buy? See ABT price chart.
  2. ABT quarterly revenue growth was 10.10%, higher than the industry and sector average revenue growth (7.64% and 6.06%, respectively). See ABT revenue growth chart.
  3. ABT forward dividend yield is 1.87%, higher than the industry (0.15%) and sector (0.20%) forward dividend yields. See ABT forward dividend chart.
  4. ABT PEG ratio (P/E adjusted for growth) is 1.78, which is low compared to its industry peers’ PEG ratios. See ABT PEG chart.
  5. ABT average analyst rating is Buy. See ABT analyst rating chart.
  6. ABT average analyst price target ($124.39) is above its current price ($96.76). See ABT price target chart.


  1. ABT profitability is declining. The YoY profit margin change was -2.36 percentage points. See ABT profitability chart.
  2. ABT short interest (days to cover the shorts) ratio is 3.31. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ABT short interest ratio chart.